Insider Transactions in Q3 2025 at Insmed Inc (INSM)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Bona fide gift
|
Direct |
23,303
-29.21%
|
-
|
|
Sep 02
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,272
-5.82%
|
$3,470,896
$143.6 P/Share
|
|
Sep 02
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,780
+13.9%
|
$383,400
$30.46 P/Share
|
|
Sep 02
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
186,648
-16.96%
|
$26,690,664
$143.65 P/Share
|
|
Sep 02
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,648
+11.74%
|
$4,479,552
$24.71 P/Share
|
|
Aug 20
2025
|
Melvin Md Sharoky Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.51%
|
$1,290,000
$129.5 P/Share
|
|
Aug 19
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-9.9%
|
$3,175,000
$127.85 P/Share
|
|
Aug 18
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,865
-0.96%
|
$878,720
$128.61 P/Share
|
|
Aug 18
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,865
+2.77%
|
$68,650
$10.85 P/Share
|
|
Aug 14
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.83%
|
$1,270,000
$127.48 P/Share
|
|
Aug 13
2025
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
5,000
+42.2%
|
-
|
|
Aug 13
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Indirect |
15,000
-94.34%
|
-
|
|
Aug 13
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
6,100
-2.1%
|
-
|
|
Aug 12
2025
|
Melvin Md Sharoky Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.33%
|
$1,210,000
$121.58 P/Share
|
|
Aug 04
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$744,470
$109.8 P/Share
|
|
Aug 04
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Aug 04
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,715
-9.49%
|
$949,935
$109.5 P/Share
|
|
Aug 04
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,715
+8.67%
|
$165,585
$19.74 P/Share
|
|
Jul 21
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
58,400
-25.34%
|
$5,956,800
$102.7 P/Share
|
|
Jul 21
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,888
+9.45%
|
$1,388,752
$29.62 P/Share
|
|
Jul 15
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
933
-1.39%
|
$95,166
$102.51 P/Share
|
|
Jul 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$696,660
$102.56 P/Share
|
|
Jul 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jul 11
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
748
-1.1%
|
$71,808
$96.41 P/Share
|
|
Jul 07
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,764
-22.99%
|
$5,487,580
$95.93 P/Share
|
|
Jul 07
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,888
+8.56%
|
$1,149,312
$24.33 P/Share
|
|
Jul 01
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$669,340
$98.72 P/Share
|
|
Jul 01
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|